Kaya Limited · NSE:KAYA
Kaya — Q1 FY21 Earnings Presentation
32 slides from Kaya's earnings presentation, Aug 14, 2020
Slide 1: Cover letter to stock exchanges: performance update
August 14, 2020 To, BSE Limited National Stock Exchange of India Limited Market Operations Department, 'Exchange Plaza', 5th Floor, 1st Floor, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block, Dalal Street, Bandra Kurla Complex, Mumbai – 400001 Bandra(E), Mumbai 400051 BSE Scrip Code: 539276 NSE Sym
Slide 2: Q1 FY21 Investor Update
Q1 FY21 Investor Update
Slide 3: Disclaimer
This investor presentation has been prepared by Kaya Limited (“Kaya”) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered or supplied should not be deemed to co
Slide 4: Tables of content
Tables of content 1 3 About Us Q1 Highlights 2 4 Our response to Q 1 Financial COVID-19
Slide 5: About us
About us Company at a glance
Slide 6: A new age business - creating the market
Premium Skin and Hair Care ser vices Dermatologist bac ked, USFDA Safe Tec hnology and products brand • Incorporated in 2003, Kaya is a pioneer in speciality • All services and products designed and formulated by in- skin & hair care with a Unique Business Model; a house dermatologists at Kaya’s R&D
Slide 7: Our Presence - India
Our Presence - India 16 Indian States 24 Cities 73 Clinics 500+ Product Retail Outlets
Slide 8: Our Presence – Middle East
Our Presence – Middle East 23 Clinics 3 Countries 9 Cities
Slide 9: Kaya Expert Service Categories in Skin and Hair Care
Kaya Expert Service Categories in Skin and Hair Care Acne & Scar Brightening and Laser Hair Hair Care Youth Contouring Treatment Pigmentation Reduction Services Dermal Fillers, Wrinkles Chemical Peels, Acne-Scar Insta Clarity Laser US-FDA approved advance Hair Health and Scalp solutions Reduction wi
Slide 10: Kaya Expert Products across Skin and Hair Need States
Kaya Expert Products across Skin and Hair Need States Researched and Developed by Kaya’s in-house, expert Dermatologists Acne Brightening Everyday Essentials Anti-Ageing Derma Natural Hair
Slide 11: Updated technology/Largest Pool of Dermatologists
Updated technology/Largest Pool of Dermatologists
Slide 12: State-of-the-art clinics
State-of-the-art clinics
Slide 13: The Target audiences
The Target audiences • Services: NCSS A, 18-45 Years • Products: NCSS A/B 18-35 Years • Working Professional/Housewives • Living In The Metros and Tier 1 cities • Digital First • Gaining Beauty Exposure • High Beauty Aspirations and seeking customised and expert solutions
Slide 14: Our response to COVID-19
gas Our response to COVID - 19
Slide 15: Managing Costs and Cash Flow; Omnichannel
Business • Customer Engagement during lockdown through digital medium Continuity • Enhanced safety measures complying to WHO guideline across clinics • Introduction of web consultation • Focus on clinics having long term potential and stronger performance Managing Costs • Leaner and more efficient b
Slide 16: Top safety claims based on WHO guidelines
Top safety claims based on WHO guidelines • 60+ safety measures • 100% Clinic staff certified on safety procedures • Appointments only through pre-booking • Temperature checks for everyone • Self declaration for all customers • UVC sanitization in all clinics • SITRA certified PPE Kits for all opera
Slide 17: Highest Safety Standards in the Category – Middle East
Highest Safety Standards in the Category – Middle East • List of 110 internal protocols, covering ‘Customer’ & ‘Employee Safety & hygiene’. Surpassing protocols set out by health authorities • At various stages: • While booking an appointment • Walking into the clinic • During the Service • Declarat
Slide 18: Q1 Highlights
wh Q 1 Highlights
Slide 19: What did we do post COVID-19 unlock
What did we do post COVID-19 unlock. Consumer Behaviour Post Our Action COVID-19 o Conduct a survey among our top consumers to understand their requirements o Dial up safety protocols in our clinics and communicate the same on multiple platforms Overtly Safety Conscious – Wary to o Focus on the serv
Slide 20: Our COVID-19 Digital Initiatives
Our COVID-19 Digital Initiatives PHASE I PHASE II PHASE III Insight : Search trends rise for online experts Insight: The gloom of the sudden lockdown Insight : Search trends rise for home skin care Action: Live sessions with Kaya Action: #StayInWithKaya - The Wellness Action: Skin Care Tips | DIY Sc
Slide 21: Kaya Social Influencers
Kaya Social Influencers
Slide 22: Innovations – Relevant, pull in new segment of customers
Innovations – Relevant, pull in new segment of customers New Trend in Aesthetic Launched in Dubai – a Innovative Face Therapy Enzymatic Resurfacing for Clinics in the region – IV revolutionary non- – Protocol from the US. Acne Scars, Stretch Boost launched just invasive technology that Launched acro
Slide 23: Q1 Financial
Q1 Financial
Slide 24: Group Highlights – Q1
Group Highlights – Q1 • Clinic business in India was impacted heavily due to shut down in Q1. Business resumed progressively from 20 clinics opening on 8th June to 50 clinics by end of June • Rising COVID-19 cases in India & intermittent changes in regulations impacted stable operations in Supply Ch
Slide 25: Kaya Group Highlights
Kaya Group Highlights Collection (INR Crs) Net Revenue (INR Crs) 150 150 115.4 • COVID – 19 impacted clinics business significantly 100.5 100 100 • Overall Collection of Q1FY21 was at 21% (INR 24.5 crs)of Q1FY20. 50 24.5 50 23.9 • Middle East collection for the month of June’2020 was at 67 0 0 % of
Slide 26: Kaya India Highlights
Kaya India Highlights 60 Net Revenue excl Royalty (INR Crs) • Net Revenue was at 10% of Q1FY20 performance. 50 49 • Service revenue was at 4% of Q1FY20 performance. 40 36 • Product revenue was 26% of Q1FY20 performance 30 (Contributed 70% of the Overall Revenue ) 20 13 • E-commerce revenue recovered
Slide 27: Kaya Middle East Highlights
Kaya Middle East Highlights • Collection at 35% of Q1FY20. • Net Revenue for Q1FY21 at INR 18.9 crs, at 37% of Q1FY20 • EBITDA at INR (6.2) crs (-33% of NR) as compared to INR 6.0 crs (12% of NR) over Q1FY20 • PAT at INR (14.4) crs (-76% of NR) as compared to INR (3.5) crs (-7% of NR) in Q1FY20. • C
Slide 28: Financial Highlights : Kaya Group
Financial Highlights : Kaya Group Particulars (INR crs) Q1 FY21 Q1 FY20 Collection -80% at constant 79% Collection 24.5 115.4 currency Net Revenue* 23.9 100.5 76% Net Revenue -79% at constant currency EBITDA (13.4) 13.8 EBITDA margin at -56% of NR Operating Margin (28.8) (3.5) against 14% of NR LY P
Slide 29: Financial Highlights : India
Financial Highlights : India Particulars (INR crs) Q1 FY21 Q1 FY20 90% Collection SSG at -90% Collection 5.9 62.1 89% Net Revenue 5.4 50.4 Net Revenue SSG at -90% EBITDA (7.2) 7.8 EBITDA margin at -133% of NR against 15% of NR LY Operating Margin (15.6) (2.0) Operating Margin at -289% of NR CY as co
Slide 30: Financial Highlights : Middle East
Financial Highlights : Middle East Particulars (INR crs) Q1 FY21 Q1 FY20 Collection -68% at constant Collection 18.6 53.3 65% currency Net Revenue 18.9 51.5 63% Net Revenue -66% at constant currency EBITDA (6.2) 6.0 Operating margin at –70% of NR, as against -3% of NR in LY Operating Margin (13.2) (
Slide 31: Financial Highlights : Q1FY21
Financial Highlights : Q1FY21 Kaya India Kaya Middle East Kaya Group Particulars (Rs in Crs) Q1 FY21 Q1 FY20 Gr % Q1 FY21 Q1 FY20 Gr % Q1 FY21 Q1 FY20 Gr % Collection -80% at constant Collection 5.9 62.1 -90% 18.6 53.3 -65% 24.5 115.4 -79% currency Net Revenue* 5.4 50.4 -89% 18.9 51.5 -63% 23.9 100.
Slide 32: Thank You
Thank You